IE781866L - Dibenzocycloheptenimines - Google Patents

Dibenzocycloheptenimines

Info

Publication number
IE781866L
IE781866L IE781866A IE186678A IE781866L IE 781866 L IE781866 L IE 781866L IE 781866 A IE781866 A IE 781866A IE 186678 A IE186678 A IE 186678A IE 781866 L IE781866 L IE 781866L
Authority
IE
Ireland
Prior art keywords
phenylalkyl
cycloalkylalkyl
alkenyl
alkyl
dialkylaminoalkyl
Prior art date
Application number
IE781866A
Other versions
IE47355B1 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Priority to IE2802/82A priority Critical patent/IE47356B1/en
Publication of IE781866L publication Critical patent/IE781866L/en
Publication of IE47355B1 publication Critical patent/IE47355B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

This invention provides 5-substituted- 10,11-dihydro-5H-dibenzo[a, d]cyclohepten-5,10-imines and their salts, methods of preparing such compounds and pharmaceutical compositions containing them. The free-base forms have the formula <IMAGE> where R is hydrogen; alkyl, alkenyl, phenylalkyl, halophenylalkyl, alkylphenylalkyl, cycloalkyl, cycloalkylalkyl or dialkylaminoalkyl, R<1> is hydrogen, alkyl, alkenyl, phenylalkyl, cycloalkyl or cycloalkylalkyl, CH2R<2> is alkyl, alkenyl, phenylalkyl, cycloalkylalkyl, dialkylaminoalkyl or hydroxyalkyl, and R<3> and R<4> are H, halogen, alkoxy, CF3S-, -CN, -COOH or -OH and are useful as antianxiety agents, muscle relaxants and in the treatment of extrapyramidal disorders such as in Parkinson's disease. [GB2004872A]
IE1866/78A 1977-09-19 1978-09-15 Dibenzocycloheptenimines IE47355B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE2802/82A IE47356B1 (en) 1977-09-19 1978-09-15 Debenzocycloheptenimines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83463977A 1977-09-19 1977-09-19

Publications (2)

Publication Number Publication Date
IE781866L true IE781866L (en) 1979-03-19
IE47355B1 IE47355B1 (en) 1984-02-22

Family

ID=25267426

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1866/78A IE47355B1 (en) 1977-09-19 1978-09-15 Dibenzocycloheptenimines

Country Status (33)

Country Link
JP (1) JPS5463100A (en)
AR (1) AR231544A1 (en)
AT (1) AT370103B (en)
AU (1) AU520178B2 (en)
BE (1) BE870562A (en)
CA (1) CA1129850A (en)
CH (1) CH637954A5 (en)
CY (1) CY1283A (en)
DE (1) DE2840786A1 (en)
DK (1) DK153843C (en)
ES (7) ES473492A1 (en)
FI (1) FI65618C (en)
FR (1) FR2403334A1 (en)
GB (2) GB2061947B (en)
GR (1) GR65703B (en)
HK (1) HK30885A (en)
HU (1) HU180868B (en)
IE (1) IE47355B1 (en)
IL (1) IL55521A0 (en)
IT (1) IT1113279B (en)
KE (1) KE3501A (en)
LU (1) LU80262A1 (en)
NL (1) NL191488C (en)
NO (1) NO151861C (en)
NZ (1) NZ188361A (en)
PH (1) PH15920A (en)
PL (3) PL118478B1 (en)
PT (1) PT68544A (en)
SE (1) SE437520B (en)
SG (1) SG9585G (en)
SU (2) SU895288A3 (en)
YU (1) YU41432B (en)
ZA (1) ZA785291B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232158A (en) * 1979-06-04 1980-11-04 Merck & Co., Inc. 10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imines
US4477668A (en) * 1982-04-07 1984-10-16 Merck & Co., Inc. Process for 5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine
GB8719199D0 (en) * 1987-08-13 1987-09-23 Merck Sharp & Dohme Chemical compounds
US5686614A (en) * 1995-04-11 1997-11-11 Neurogen Corporation Preparation of chiral 5-aminocarbonyl-5H-dibenzo a,d!cyclohepten-5,10-imines by optical resolution
US5739337A (en) * 1996-03-08 1998-04-14 Neurogen Corporation Process for preparing dibenzo-1-carboxamido-1,4-azabicyclo 3.2.1!octanes
US10583171B2 (en) 2015-11-30 2020-03-10 INSERM (Institut National de la Santé et de la Recherche Médicale) NMDAR antagonists for the treatment of diseases associated with angiogenesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794904A (en) * 1972-02-04 1973-08-02 Roussel Uclaf NEW DIBENZOCYCLOHEPTENE DERIVATIVES AND THEIR PREPARATION
BE829075A (en) * 1974-05-15 1975-11-14 9,10-DIHYDROANTHRACEN-9,10-IMINES SUBSTITUTES AND THEIR HETEROCYCLIC ANALOGUES (AZA)

Also Published As

Publication number Publication date
FI782680A (en) 1979-03-20
IL55521A0 (en) 1978-12-17
GR65703B (en) 1980-10-22
AU3966878A (en) 1980-03-13
YU219678A (en) 1983-02-28
NZ188361A (en) 1982-06-29
ES483287A1 (en) 1980-04-16
YU41432B (en) 1987-06-30
HK30885A (en) 1985-04-26
PL121605B1 (en) 1982-05-31
NL7808847A (en) 1979-03-21
SE7809187L (en) 1979-03-20
NO151861C (en) 1985-06-19
PH15920A (en) 1983-04-22
ES483288A1 (en) 1980-04-16
GB2004872A (en) 1979-04-11
GB2061947B (en) 1982-08-04
SG9585G (en) 1985-08-08
FR2403334A1 (en) 1979-04-13
DK389978A (en) 1979-03-20
IT1113279B (en) 1986-01-20
JPS5463100A (en) 1979-05-21
CA1129850A (en) 1982-08-17
ES473492A1 (en) 1980-07-16
PL118478B1 (en) 1981-10-31
SE437520B (en) 1985-03-04
FI65618C (en) 1984-06-11
SU915800A3 (en) 1982-03-23
FR2403334B1 (en) 1982-11-19
CH637954A5 (en) 1983-08-31
ES483283A1 (en) 1980-04-16
SU895288A3 (en) 1981-12-30
ES483286A1 (en) 1980-04-16
ZA785291B (en) 1980-04-30
IT7851126A0 (en) 1978-09-18
NO783017L (en) 1979-03-20
CY1283A (en) 1985-07-05
ATA669778A (en) 1982-07-15
ES483285A1 (en) 1980-09-01
DE2840786A1 (en) 1979-03-22
LU80262A1 (en) 1979-06-01
AU520178B2 (en) 1982-01-21
NL191488B (en) 1995-04-03
KE3501A (en) 1985-02-22
GB2004872B (en) 1982-04-15
FI65618B (en) 1984-02-29
DE2840786C2 (en) 1987-05-21
IE47355B1 (en) 1984-02-22
DK153843C (en) 1989-01-23
ES483284A1 (en) 1980-09-01
PL209632A1 (en) 1979-06-04
BE870562A (en) 1979-03-19
GB2061947A (en) 1981-05-20
NO151861B (en) 1985-03-11
AR231544A1 (en) 1984-12-28
PL112834B1 (en) 1980-11-29
JPS5639315B2 (en) 1981-09-11
NL191488C (en) 1995-08-04
PT68544A (en) 1978-10-01
DK153843B (en) 1988-09-12
AT370103B (en) 1983-03-10
HU180868B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
MX9801305A (en) Oral fast-dissolving compositions for dopamine agonists.
GR3017996T3 (en) 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
GR3033528T3 (en) Novel piperidine derivatives with paf antagonist activity
KR900001693A (en) Azacyclic Compounds, Methods for Preparing the Same, and Uses thereof
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it&#39;s preparation,use of the compound and pharmaceutical compositions containing the same
IE781866L (en) Dibenzocycloheptenimines
ZA824403B (en) 1-aryl 2-aminomethyl cyclopropane carboxylates (z), their preparation and use as useful drugs in the treatment of different pains
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
ZA949593B (en) N-substituted azabicycloheptane derivatives their preparation and use
ES2006619A6 (en) Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation.
IL100458A0 (en) Pharmaceutical compositions containing antagonists of the quisqualate receptor
GB2004550A (en) Dibenzocycloocten-imines
ES2009689A6 (en) Derivatives of 3-piperidine carbaldehyde oxime and their use as medicaments
NZ504124A (en) Phenyl-alkyl-imidazoles and use in treating inflammatory disease
AU8789282A (en) 4-(w-(1,2-dihydro-2-oxo-quinoline-3-caroxamido)-alkyl)- benzene-sulfonyl ureas
CZ91995A3 (en) Gestagen-active 19,11-bridged 4-esterenes, process of their preparation and intermediate for preparing thereof
IL83088A0 (en) Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them
ES481207A1 (en) Imino-bridged benzocycloheptapyridines, process for their preparation and pharmaceutical composition thereof.
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
TW362097B (en) 3-Phenyl-1, 4-dialkyl-1,2,4-triazolium salts and their use as antidepressants

Legal Events

Date Code Title Description
MK9A Patent expired